戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e breast cancer resembled that of late-onset female breast cancer.
2 y, male breast cancer is often compared with female breast cancer.
3 es in excess relative and absolute risk from female breast cancer.
4 s for radiotherapy, by stage, are similar to female breast cancer.
5 r information for comparison with studies of female breast cancer.
6  predisposition to ovarian cancer as well as female breast cancer.
7 of which had a family history of male and/or female breast cancer.
8 ranging from 31% for any leukemia to 89% for female breast cancer.
9 cess relative and absolute risks of male and female breast cancers.
10  etiology of male breast cancers, similar to female breast cancers.
11 CHEK2 had three times the population risk of female breast cancer (145 cases: SIR 3.48 (95% CI 2.96-4
12 n-associated relative risk for male than for female breast cancer, although absolute excess risks for
13 ds in the age-adjusted incidence of invasive female breast cancer and compared these with trends in t
14 rphism was associated with increased risk of female breast cancer and may modify the relation between
15 nown associations of ionizing radiation with female breast cancer, and emerging evidence also for mal
16 s showed a >100-fold higher risk of sarcoma, female breast cancer, and hematologic malignancies for t
17  of families with multiple case, early onset female breast cancer, and they are also associated with
18 late effect of concern, using second-primary female breast cancer as an example.
19 ed significantly over time for both male and female breast cancer, but progress for men has lagged be
20 s analyzed data from a case-control study of female breast cancer conducted in Connecticut in 1994-19
21 gram collected 600,000+ in situ and invasive female breast cancers during the years 1950 to 2003.
22                       In the United Kingdom, female breast cancer following occupational radiation ex
23 ecrease in the overall incidence of invasive female breast cancer in the United States was reported.
24               Bias in age-adjusted trends in female breast cancer incidence is shown graphically befo
25 ely, of relative risk for male compared with female breast cancer incidence, the former borderline si
26  the investigation of birth cohort trends in female breast cancer mortality rates obtained from the N
27                           Male compared with female breast cancers occurred later in life with higher
28 focus group feedback, was administered to 95 female breast cancer participants twice within 1 to 2 we
29 s were established from blood samples of 100 female breast cancer patients and 105 healthy controls.
30 spanic, African American, and Asian American female breast cancer patients compared with non-Hispanic
31 28F heterozygotes were 2.88% (47/1632) among female breast cancer patients not selected for family hi
32 t diagnosis was investigated in over 106,000 female breast cancer patients reported during 1992-1996
33 in a population-based, multiethnic series of female breast cancer patients younger than 65 years at d
34     Mutations were detected in both male and female breast cancer patients.
35 demiologic findings on cigarette smoking and female breast cancer risk may reflect insufficient asses
36  9.51; 95% CI, 1.15 to 34.37; P = .009), and female breast cancer (SIR, 3.95; 95% CI, 1.59 to 8.13; P
37             One hundred twenty-three healthy female breast cancer survivors and 87 women without canc
38 large, population-based cohort study of 5042 female breast cancer survivors in China.
39                                        Sixty female breast cancer survivors with hot flashes were ran
40       A self-report measure of body image in female breast cancer survivors, the Body Image and Relat
41  and reproductive health outcomes in younger female breast cancer survivors.
42  in the home, is associated with the risk of female breast cancer, the authors analyzed data from a p
43 kemia, testicular cancer, ovarian cancer, or female breast cancer treated with chemotherapy.
44 vestigated in a nested case-control study of female breast cancer within a cohort of African American

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。